BTS Appointed Exclusive Global A2P SMS Aggregator for BBIX and SoftBank Corp.
20.1.2025 07:00:00 CET | Business Wire | Press release
Business Telecommunications Services, Inc. (BTS), a leading provider, technology enabler, and trusted partner to CommTech players, has today announced its appointment as the exclusive international A2P SMS aggregator for BBIX, Inc. (BBIX), a wholly-owned subsidiary and the official international A2P SMS gateway of SoftBank Corp. (SoftBank). This agreement marks a significant milestone in the five-year partnership between BTS, BBIX, and SoftBank, enabling seamless and innovative international communication solutions.
As the exclusive aggregator, BTS will be the official channel for terminating international A2P SMS traffic to the SoftBank network. This partnership mandates all communications providers to route their traffic destined for SoftBank through BTS, ensuring seamless and secure delivery. By leveraging the complementary strengths of each company, this partnership enhances the global messaging ecosystem with improved operational efficiencies, enabling a better customer experience and more responsive customer support.
BTS's extensive global footprint and BBIX's market expertise will help partners navigate complex regulatory environments, expand market reach, and unlock cross-selling opportunities that can drive higher revenue growth. The partnership also ensures the delivery of secure and reliable messaging services by leveraging BTS’s advanced S1 Platform.
“As a trusted partner, we are pleased to expand our collaboration with BTS to ensure the seamless aggregation of global A2P SMS traffic,” said Hideyuki Sasaki, President & CEO of BBIX. “By combining our strengths and complementary expertise, we are delivering a secure and reliable solution that enhances the SoftBank network and supports the evolving needs of our global partners.”
“As a trusted partner and joint venture collaborator, BTS has consistently demonstrated the capabilities and expertise we need to support SoftBank’s global communications strategy,” commented Norioki Sekiguchi, Vice President of SoftBank Corp.’s Global Business Division. “By leveraging BBIX as our official gateway, BTS will ensure the seamless and secure aggregation of international A2P SMS traffic to our network, enabling us to deliver greater reliability and performance for our customers worldwide.”
This agreement solidifies BTS’s leadership in the global messaging space and underscores the ongoing collaboration between BTS, BBIX, and SoftBank. Together, they continue to pioneer innovative and scalable solutions that address the dynamic needs of the global communications industry.
“Becoming the exclusive aggregator of A2P SMS for BBIX and SoftBank marks an important milestone in our partnership, which began over five years ago,” concluded Andrés Proaño, EVP & CRO of BTS. “This collaboration reflects the strength of our relationship and our shared commitment to driving innovation in global communications. With many more strategic initiatives ahead, such as Open Connectivity eXchange (OCX), Roaming Peering eXchange (RPX), and advanced AI solutions, this agreement is a key step forward in a partnership poised for even greater growth and success.”
About BTS
BTS is a leading global provider, technology enabler, and trusted partner to CommTech players. Leveraging its proprietary S1 Platform and an international network of 400+ direct partners, BTS delivers advanced AI-driven solutions specializing in voice, messaging, cloud communications, and innovative services that drive growth for MNOs, carriers, digital players, and hyperscalers. BTS powers 18+ billion voice minutes annually across 180+ countries, with extensive cloud telephony coverage in 90+ hard-to-reach markets and global reach for messaging services.
About BBIX
BBIX was established in 2003 to be a carrier-free internet exchange (IX) provider headquartered in Japan and serving Asia, Europe, and the US. It provides various connectivity services such as IX, Roaming Peering eXchange (RPX), Open Connectivity eXchange (OCX), as well as A2P SMS solutions. BBIX has established itself as one of the leading IXs in Asia, with a growing membership and an expanding global footprint.
View source version on businesswire.com: https://www.businesswire.com/news/home/20250119536400/en/
Subscribe to releases from Business Wire
Subscribe to all the latest releases from Business Wire by registering your e-mail address below. You can unsubscribe at any time.
Latest releases from Business Wire
2PointZero Group Signals Global Scale With Revenue Surge to AED 21.9 Billion and Net Profit of AED 7.7 Billion in H1 202631.7.2026 13:42:00 CEST | Press release
Group revenue growth supported by stable gross profit margin of 29%, and adjusted EBITDA of AED 5.0 billionGlobal expansion milestones include the completed sale of TAQA stake, and the acquisition of Traverse Midstream Partners in North America, Baobab Group in Africa, and 60.8% of ISEM in ItalyTIME ranks the Group 36th on the World’s Growth Leaders list for 2026, highlighting market stability, operational scale and disciplined approach to capital 2PointZero Group (ADX: 2POINTZERO), a leading Abu Dhabi-based investment holding firm, announced its financial results for the first half of 2026, reporting revenue of AED 21.9 billion and delivering a Group Net Profit of AED 7.7 billion. This robust performance is reflected in the Group’s adjusted EBITDA, which reached AED 5.0 billion after excluding fair value changes and one-offs. This press release features multimedia. View the full release here: https://www.businesswire.com/news/home/20260731538982/en/ Samia Bouazza, CEO of 2PointZero (P
Datroway® Approved in the EU as Only TROP2 Directed Medicine with Overall Survival Benefit for the First-Line Treatment of Patients with Metastatic TNBC Who Are Not Candidates for Immunotherapy31.7.2026 08:30:00 CEST | Press release
Approval based on TROPION-Breast02 phase 3 trial results where Daiichi Sankyo and AstraZeneca’s Datroway showed a statistically significant and clinically meaningful improvement for the dual primary endpoints of overall survival and progression-free survival Datroway now approved for two breast cancer indications in the EU Datroway® (datopotamab deruxtecan) has been approved in the European Union (EU) as monotherapy for the first-line treatment of adult patients with unresectable or metastatic triple negative breast cancer (TNBC) who are not candidates for PD-1/PD-L1 inhibitor therapy. Datroway is a specifically engineered TROP2 directed DXd antibody drug conjugate (ADC) discovered by Daiichi Sankyo (TSE: 4568) and being jointly developed and commercialized by Daiichi Sankyo and AstraZeneca (LSE/STO/NYSE: AZN). The approval by the European Commission follows the positive opinionof the Committee for Medicinal Products for Human Use of the European Medicines Agency and is based on result
Polpharma Biologics Announces FDA and EMA Acceptance for Review of PB016 Vedolizumab Biosimilar Candidate31.7.2026 08:30:00 CEST | Press release
Polpharma Biologics International AG today announces that the U.S. Food and Drug Administration (FDA) and the European Medicines Agency (EMA) have accepted for review the Biologics License Application (BLA) and Marketing Authorisation Application (MAA), respectively, for PB016, a proposed vedolizumab biosimilar candidate to Takeda’s reference product Entyvio®* (vedolizumab) lyophilized vial for intravenous (IV) administration for the treatment of adults with moderately to severely active ulcerative colitis and Crohn's disease. The BLA and MAA acceptances represent significant milestones in Polpharma Biologics' development program and underscore the company's commitment to advancing high-quality biosimilars and expanding global access to affordable biologic medicines. "FDA and EMA acceptances for review of our IV vedolizumab biosimilar candidate mark a major achievement for Polpharma Biologics and validate our deep scientific expertise in biosimilar development and manufacturing," said
SES: Disclosure of Share Buyback Transactions31.7.2026 07:30:00 CEST | Press release
In the time period from June 2, 2026 until and including June 23, 2026, a number of 213,167 shares were bought back within the framework of the share buyback of SES to meet obligations under SES’s Equity Based Compensation Plan (EBCP). Shares were bought back as follows: Day of purchase Aggregated volume in shares Daily weighted average acquisition price of shares (EUR) Market June 2, 2026 27,097 8.8727 DXE June 2, 2026 72,903 8.8556 ENX June 5, 2026 16,624 8.3723 DXE June 5, 2026 31,510 8.4266 ENX June 15, 2026 26,451 7.8423 XPAR June 17, 2026 26,812 7.3910 XPAR June 23, 2026 11,770 7.2200 XPAR The transactions in a detailed form are published on SES’s website: https://www.ses.com/investors/shareholder-information/share-buy-backs. Follow us on: Twitter | Facebook | YouTube | LinkedIn | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, busin
Half-Year Report on SES’s Liquidity Contract31.7.2026 07:30:00 CEST | Press release
Pursuant to the liquidity contract entered into by SES with BNP Paribas as of 7 April 2026, please see the below update on the progress of the liquidity services. When the liquidity services were implemented as of 7 April 2026, the following assets were in the liquidity account: € 2,500,000 As of 30 June 2026, the following assets appeared on the liquidity account: 228,186 shares; € 816,880. Over the period from 7 April 2026 to 30 June 2026, the following transactions were executed: 1,082 buy transactions; 1,308 sales transactions. Over this same period, the volumes traded represented: 1,093,335 shares and € 8,485,986 on the buy side; 873,399 shares and € 6,860,843 on the sell side. Follow us on: LinkedIn | Facebook | YouTube | X | Instagram Read our Blogs > Visit the Media Gallery > About SES At SES, we believe that space has the power to make a difference. That’s why we design space solutions that help governments protect, businesses grow, and people stay connected—no matter where th
In our pressroom you can read all our latest releases, find our press contacts, images, documents and other relevant information about us.
Visit our pressroom